%0 Journal Article
%T Novel oral anticancer drugs: perspectives and limitations
%A Hans-Peter Lipp
%J European Journal of Oncology Pharmacy
%D 2011
%I Pharma Publishing & Media Europe
%X Within the last decade, the development of novel, orally available anticancer drugs has made great progress, but this oral treatment requires the same amount of patient instruction as IV treatments.
%U http://www.ppme.eu/Publications/EJOP/Journal-information/Previous-issues/EJOP-Vol.5-2011-Issue-1/Cover-Story/Novel-oral-anticancer-drugs-perspectives-and-limitations